News
11d
Parade on MSNWalmart Is Selling a 'Beautiful' $38 Swim Dress for Just $20, and Reviewers Say It’s 'Perfect For a Family Vacation'This swimdress from Walmart is fashionable and high-coverage, and the flash deal has lowered the price to only $20. The ...
The S&P 500 notched a modest advance, while tech boosted the Nasdaq to a more substantial gain. The blue-chip Dow ended the session barely in positive territory. The greenback, under pressure amid ...
“This is a sad state of affairs for our state, and the appropriations committee should be ashamed for killing such a modest bill,” said Angela Graham-Houweling, executive director of the Siren ...
Major acts coming to Louisville in June include Anderson East, Modest Mouse, John Cusack, Justin Moore & Joe Nichols, and more. This story has been updated to remove a concert that move to July.
In 2004, "Psychology Today" published an article, "The First Impression," that illustrated how brief it takes to make an impression during work interactions like interviews. Psychologists proved ...
Despite heightened military tensions between Pakistan and India in May, militant groups were unable to significantly escalate their activities in Pakistan, according to data released by the ...
Semi-modest is hottest, as the old adage goes. They’re also a win for light packers who don’t have space for multiple cover-ups (though if you’re in the market, I shared my favorites here ...
Slowly but surely summer is inching closer, and that means swimsuit season is almost upon us. As you prepare your pool and beach wardrobe, remember that, when choosing swimsuits, function is just ...
Japanese Yen (JPY) is entering Thursday’s NA session with a modest gain against the US Dollar (USD), a lone performer in an environment of mild (albeit broad-based) USD strength, Scotiabank's ...
Kenanga Research expects the final aggregator margin to be “modest”. While the details of the gas aggregation profit share for Sarawak are not disclosed, the research house believes that the ...
German drugmaker Boehringer Ingelheim has released full Phase III results for its experimental lung disease drug nerandomilast, showing it met primary endpoints in both idiopathic pulmonary fibrosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results